no more compounded semaglutide Hims? Hers? It's Novo Nordisk's Market Now Safest and Cheapest Compounding Pharmacy

Phase II clinical trial results demonstrated: Body weight reduction of up to 2% at 48 weeks ( vs 2.1% placebo ) 83% of participants achieved 15% body weight loss at highest dose HbA1c reduction of up to 02% in Type 2 Diabetes participants ( vs 0% placebo ) Normalization of liver fat in 86% of participants with hepatic steatosis Reduction in systolic blood pressure averaging 6-8 mmHg These Phase II findings are preliminary

Use bacteriostatic water for reconstitution if you plan to use the solution over multiple days

Probiotic safety and risk factors

This makes it the first triple-agonist peptide to reach advanced clinical development

If you've had these labs completed within the past 24 months, you may not need labs ordered during your initial consultation, but this decision will be made by your provider